Mariposa-2: Amivantamab Following Progression on Osimertinib in EGFR-Mutated NSCLC Lung 2 Mins Read17 Author: Dr Antonio Passaro (on-camera comments) – Courtesy of ESMO.org At the ESMO 2023 conference, the results of the Phase three…
